GlassScriptPhysician profile
Thomas John Wade
NPI 1366615718
$5,713.11
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $97.00 · 2021: $1,244 · 2022: $521 · 2023: $1,410 · 2024: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,020 · Food and Beverage: $374 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,019.58 |
| Food and Beverage | $374.43 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,175.45 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $158.10 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $150.71 | 2019-2020 | |
| Ethicon US, LLC | $38.82 | 2019 | |
| Abbvie INC. | $30.49 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $28.08 | 2019 | |
| Csl Behring | $26.87 | 2019 | |
| Tela Bio, INC. | $24.13 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $15.84 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.24 | 2020 | |
| Merck Sharp & Dohme LLC | $14.05 | 2019 | |
| Heron Therapeutics, INC. | $13.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.16 | 2019 | |
| Integra Lifesciences Corporation | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.